The Drug Addiction Treatment Market is projected to reach USD 38.50 billion by 2035, growing at a 7.20% CAGR, while the U.S. market is projected to reach USD 10.78 billion, advancing at 7.06% CAGR, as rapid-initiation injectable protocols and telehealth counseling widen access to medication-assisted care.

Austin, United States, Sept. 17, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Drug Addiction Treatment Market was valued at USD 19.20 Billion in 2025 and is expected to reach USD 38.50 Billion by 2035, growing at a CAGR of 7.20% from 2026 to 2035. Growth is driven by rising rates of substance abuse disorders and growing recognition of addiction as a treatable medical condition, supported by expanding government programs improving treatment access and funding. Usage of medications including buprenorphine, methadone, and naltrexone continues boosting demand for opioid dependency treatment, alongside growing investment in outpatient therapy, behavioral treatments, and personalized care solutions.


Download the Drug Addiction Treatment Market Sample Report: https://www.snsinsider.com/sample-request/3445

Drug Addiction Treatment Market Key Highlights

  • Market size, 2025: USD 19.20 Billion
  • Market forecast, 2035: USD 38.50 Billion
  • CAGR: 7.20% from 2026 to 2035
  • Largest region: North America, approximately 36.09% share in 2025
  • Fastest-growing region: Asia Pacific
  • Largest type: Opioid Addiction, approximately 44.60% share in 2025
  • Fastest-growing type: Stimulant Addiction, approximately 8.60% CAGR
  • Largest treatment: Therapy, approximately 52.00% share in 2025
  • Fastest-growing treatment: Rehabilitation Programs, approximately 7.80% CAGR
  • Largest route of administration: Oral, approximately 42.67% share in 2025
  • Fastest-growing route of administration: Injectable, approximately 8.40% CAGR
  • Largest care delivery setting: Rehabilitation Centers, approximately 38.60% share in 2025
  • Fastest-growing care delivery setting: Outpatient Clinics, approximately 8.20% CAGR
  • Largest distribution channel: Hospital Pharmacies, approximately 44.20% share in 2025
  • Fastest-growing distribution channel: Online Pharmacies, approximately 8.80% CAGR

Market Relevance

Drug addiction treatment has become an increasingly urgent global health priority, with the World Health Organization estimating that 39.5 million people worldwide suffer from substance abuse disorders. Cultural and policy shifts that now treat substance use disorder as a medical condition rather than a moral failing continue reinforcing demand for structured, evidence-based treatment across medication-assisted therapy, counseling, and rehabilitation programs.

Drug Addiction Treatment Market Overview

The market comprises opioid and stimulant addiction treatment delivered through therapy and rehabilitation programs via oral and injectable routes, across rehabilitation centers, outpatient clinics, hospital pharmacies, and online pharmacies. Opioid addiction remains the dominant treatment category given historical overprescription, easy access to unused medications, and the availability of heroin as a cheaper substitute, while stimulant addiction is growing fastest as methamphetamine and cocaine use rise without an FDA-approved medication comparable to buprenorphine. Therapy remains foundational across nearly every treatment plan, while rehabilitation programs are expanding as addiction is increasingly recognized as requiring sustained, long-term management.

Strategic Market Outlook

Opportunities for growth lie in long-acting injectable formulations that eliminate the daily adherence burden associated with oral medications, giving manufacturers with fast-initiation, injectable protocols a real chance to capture disproportionate market share. Digital treatment expansion offers a further avenue, as telehealth counseling and monitoring services extend addiction therapy access into regions with few specialized treatment facilities.

Barriers of treatment and social stigmatization are still the most serious challenges. Only less than 50% of the 2.5 million people in the US suffering from opioid use disorder have access to medication-assisted treatment owing to the shortage of prescribing physicians and treatment centers, despite attempts at reducing the stigma.

Drug Addiction Treatment Market Regional Analysis

North America constituted about 36.09% of the total market share in 2025, accounting for the largest regional market due to the presence of robust healthcare facilities and advanced medication-assisted therapy and treatment awareness levels. In North America, the United States dominated the market with approximately 82.40% of the regional revenue share; an average of four deaths per hour due to opioid overdose was a significant factor driving steady investments in treatment infrastructure.

The U.S. Drug Addiction Treatment Market size was estimated at approximately USD 5.71 Billion in 2025 and is expected to rise to approximately USD 10.78 Billion in 2035, posting a CAGR of approximately 7.06%.

The Europe Drug Addiction Treatment Market constituted about 28.0% of the total market and was valued at USD 5.38 Billion in 2025 and is projected to reach USD 10.57 Billion by 2035, posting a CAGR of 6.90% during 2026 to 2035. In Europe, Germany constituted about 25.60% of regional revenue share in 2025, driven by robust healthcare facilities and steady investments in medication-assisted therapy and behavioral health integration.

Growth in the Asia-Pacific region will be the fastest among all regions up to 2035 due to the initiatives of China, Japan, and India regarding modern healthcare along with favorable government policies. Revenue generated in the year 2025 from the Asia-Pacific region was around 38.20%.

Middle East & Africa: The UAE had around 29.70% share in the regional revenue in 2025 due to increased investment in healthcare infrastructure as part of economic diversification.

Latin America: Revenue from Brazil in 2025 was around 35.40% due to increasing healthcare infrastructure and raising awareness about substance abuse.

Buy the Drug Addiction Treatment Market Report with Competitive Analysis at a 20% Discount: https://www.snsinsider.com/checkout/3445

Drug Addiction Treatment Market Segment Analysis

By Type: Opioid Addiction contributed a market share of about 44.60% in 2025, because of past over prescription, and availability of unused drugs. The growth of Stimulant Addiction is at an 8.60% CAGR. This is due to the increased usage of methamphetamines and cocaine in the absence of an FDA approved drug.

By Treatment: Therapy held a market share of about 52.00% in 2025, which included behavioral therapy and group therapy, which form the basis of almost all treatments. Rehabilitation Programs is the fastest growing segment, growing at a CAGR of around 7.80%, fueled by the increasing demand for recovery and relapse prevention programs.

By Route of Administration: The oral method has occupied 42.67% market share in 2025, as it was the feasible default because of cheaper costs and feasibility with the current system of dispensing from pharmacies. Injectable is the fast-growing drug delivery mode due to high 8.40% CAGR as long-lasting versions free patients from the daily use of pills.

By Care Delivery Setting: Rehabilitation Centers hold a market share of approximately 38.60% in 2025, providing the required environment needed by patients at their time of stabilization. Outpatient Clinics have the highest growth rate of approximately 8.20% CAGR due to emphasis on access by healthcare systems where patients can continue working and taking care of their families.

By Distribution Channel: Hospital Pharmacies made up a market share of about 44.20%, considering the natural access advantages that come from already being part of the healthcare system. Online Pharmacies have been the fastest-growing distribution channel, growing by an annual growth rate of about 8.80%. This is due to advancements in digital treatment.

Drug Addiction Treatment Market Key Trends

  • Long-acting injectable treatments reducing daily adherence burdens and improving treatment continuity
  • Integration of behavioral health with primary care expanding access and enabling earlier identification
  • Telehealth counseling and remote monitoring platforms improving access across underserved regions
  • Growing awareness and destigmatization positioning substance use disorder as a chronic medical condition
  • Government initiatives and funding supporting policy reforms and expanded treatment infrastructure

Competitive Landscape

The Drug Addiction Treatment Market consists of competent pharmaceutical firms and addiction treatment centers, where competition is defined by the introduction of sustained-release injectable drugs and fast-onset addiction treatment regimens.

Indivior revealed on February 24, 2025, the approval of the new label modifications of SUBLOCADE by the Food and Drug Administration to incorporate additional injection site options by subcutaneous injection in the abdomen, thigh, buttock, and upper arm. On December 17, 2025, Indivior was listed as part of the S&P SmallCap 600, indicating that it has grown considerably in its market capitalization. Various pharmaceutical firms including Teva Pharmaceutical Industries were manufacturing generic opioid agonists like methadone and buprenorphine, whereas different addiction treatment centers including Hazelden Betty Ford Foundation were negotiating further distribution deals with pharmaceutical manufacturers.

Major key players include

  • Indivior PLC
  • Alkermes plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals
  • Hikma Pharmaceuticals PLC
  • Otsuka Pharmaceutical Co., Ltd.
  • Novartis AG
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Viatris Inc.
  • Camurus AB
  • Orexo AB
  • Braeburn Inc.
  • Emergent BioSolutions Inc.
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • Hazelden Betty Ford Foundation
  • American Addiction Centers
  • Eleanor Health

Explore the Complete Drug Addiction Treatment Market Report: https://www.snsinsider.com/reports/drug-addiction-treatment-market-3445

CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com